Fichero a descargar de la publicaciÃ³n mostrada - Sociedad ...

More documents

Recommendations

Info

Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 60______________________________________________________________________________334. Kuizon D, Gordon SM, Dolmatch BL. Single-lumen subcutaneous ports inserted by interventional radiologistsin patients undergoing chemotherapy: incidence of infection and outcome of attempted catheter salvage. ArchIntern Med 2001; 161:406-10.335. Diaz Granados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients withneutropenia and enterococcal bloodstream infection. J Infect Dis 2005; 191:588-95.336. Vergis EN, Hayden MK, Chow JW, et al. Determinants of vancomycin resistance and mortality rates inenterococcal bacteremia. A prospective multicenter study. Ann Intern Med 2001; 135:484-92.337. Chee L, Brown M, Sasadeusz J, MacGregor L, Grigg AP. Gram-negative organisms predominate in Hickmanline-related infections in non-neutropenic patients with hematological malignancies. J Infect 2008; 56:227-33.338. Hung CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Nosocomial candidemia in a university hospital inTaiwan. J Formos Med Assoc 1996; 95:19-28.339. Karlowicz MG, Hashimoto LN, Kelly RE Jr., Buescher ES. Should central venous catheters be removed assoon as candidemia is detected in neonates? Pediatrics 2000; 106:E63.340. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious DiseasesSociety of America. Clin Infect Dis 2000; 30:662-78.341. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstreaminfections in the ICU. N Engl J Med 2006; 355:2725-32.342. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk forvascular catheter infection. Ann Intern Med 2000; 132:641-8.343. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a preventionstrategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355:1864-8.344. Warren DK, Zack JE, Mayfield JL, et al. The effect of an education program on the incidence of centralvenous catheter-associated bloodstream infection in a medical ICU. Chest 2004; 126:1612-8.345. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications withan intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998; 158:473-7.346. Lorente L, Jiménez A, García C, et al. Catheter-related bacteremia from femoral and central internal jugularvenous access. Eur J Clin Microbiol Infect Dis 2008; 27:867-71.347. Lorente L, Henry C, Martín MM, Jiménez A, Mora ML. Central venous catheter-related infection in aprospective and observational study of 2,595 catheters. Crit Care 2005; 9:R631-5.348. Deshpande KS, Hatem C, Ulrich HL, et al. The incidence of infectious complications of central venouscatheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med2005; 33:13-20.349. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internaljugular over the subclavian access for temporary dialysis. Nephron 1990; 54:154-61.350. Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomialevents in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008; 299:2413-22.351. Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: metaanalysis.BMJ 2003; 327:361.
Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 61______________________________________________________________________________352. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, andchlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-43.353. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5%tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin InfectDis 2000; 31:1001-7.354. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solutionfor vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136:792-801.355. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliancewith hand hygiene. Infection Control Programme. Lancet 2000; 356:1307-12.356. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by usingmaximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15:231-8.357. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheterrelatedinfection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping.Am J Med 1991; 91:197S-205S.358. Lee DH, Jung KY, Choi YH. Use of maximal sterile barrier precautions and/or antimicrobial-coated cathetersto reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008;29:947-50.359. Arrighi DA, Farnell MB, Mucha P Jr., Iistrup DM, Anderson DL. Prospective, randomized trial of rapidvenous access for patients in hypovolemic shock. Ann Emerg Med 1989; 18:927-30.360. Ahmed Z, Mohyuddin Z. Complications associated with different insertion techniques for Hickman catheters.Postgrad Med J 1998; 74:104-7.361. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheterdressing. A meta-analysis of the infection risks. JAMA 1992; 267:2072-6.362. Gillies D, O'Riordan L, Carr D, Frost J, Gunning R, O'Brien I. Gauze and tape and transparent polyurethanedressings for central venous catheters. Cochrane Database Syst Rev 2003;CD003827.363. Laura R, Degl'Innocenti M, Mocali M, et al. Comparison of two different time interval protocols for centralvenous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. TheItalian Nurse Bone Marrow Transplant Group (GITMO). Haematologica 2000; 85:275-9.364. Vokurka S, Bystricka E, Visokaiova M, Scudlova J. Once- versus twice-weekly changing of central venouscatheter occlusive dressing in intensive chemotherapy patients: results of a randomized multicenter study. MedSci Monit 2009; 15:CR107-CR110.365. Maki DG, Mermel LA, Kluger D, et al. The efficacy of a chlorhexidine-impregnated sponge (Biopatch) forthe prevention of intravascular catheter-related infection - a prospective, randomized, controlled, multicenterstudy. Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother 2000;Sep 17-20; 40:422.366. Ruschulte H, Franke M, Gastmeier P, et al. Prevention of central venous catheter related infections withchlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 2009;88:267-72.367. Timsit JF, Schwebel C, Bouadma L, et al. Chlorhexidine-impregnated sponges and less frequent dressingchanges for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA2009; 301:1231-41.368. Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural cathetercolonization and infection: a meta-analysis. J Antimicrob Chemother 2006; 58:281-7.
Page 1 and 2:
AVANCES ENENFERMEDADES INFECCIOSASP
Page 3 and 4:
Octubre 2011 INFECCIONES RELACIONAD
Page 5 and 6:
Page 7 and 8:
Page 9 and 10: Octubre 2011 INFECCIONES RELACIONAD
Page 59: Octubre 2011 INFECCIONES RELACIONAD
show all

Fichero a descargar de la publicaciÃ³n mostrada - Sociedad ...

Create successful ePaper yourself

Delete template?

Save as template?